Covered recipient · General Payments record
KATARA S CHAVIS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,699.31
- Reported across 97 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $430.46 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $145.68 | 3 |
| Amgen Inc. | $142.91 | 20 |
| Ardelyx, Inc. | $59.03 | 2 |
| ABBVIE INC. | $34.26 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $32.17 | 2 |
| Corcept Therapeutics | $16.41 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $34.26 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106907004 | CMS |
| Amgen Inc. | $7.26 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117524981 | CMS |
| Amgen Inc. | $11.40 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117524983 | CMS |
| Amgen Inc. | $8.74 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117524985 | CMS |
| Amgen Inc. | $4.57 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117524987 | CMS |
| Amgen Inc. | $12.23 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117524989 | CMS |
| Amgen Inc. | $8.07 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117524991 | CMS |
| Amgen Inc. | $10.52 | 05/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117222355 | CMS |
| Amgen Inc. | $4.92 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117524993 | CMS |
| Amgen Inc. | $2.60 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117524995 | CMS |
| Amgen Inc. | $3.82 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117524997 | CMS |
| Amgen Inc. | $16.07 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117524999 | CMS |
| Amgen Inc. | $4.41 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117222357 | CMS |
| Amgen Inc. | $4.61 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117525001 | CMS |
| Amgen Inc. | $4.62 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117222359 | CMS |
| Amgen Inc. | $4.38 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117525003 | CMS |
| Amgen Inc. | $5.48 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117525005 | CMS |
| Amgen Inc. | $2.75 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117525007 | CMS |
| Amgen Inc. | $17.73 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117222361 | CMS |
| Amgen Inc. | $3.57 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117525009 | CMS |
| Amgen Inc. | $5.16 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117525011 | CMS |
| Ardelyx, Inc. | $29.47 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146721611 | CMS |
| Ardelyx, Inc. | $29.56 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146721613 | CMS |
| AstraZeneca Pharmaceuticals LP | $113.56 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104481336 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.40 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105648596 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.72 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105312281 | CMS |
| Corcept Therapeutics | $16.41 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117781871 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.83 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153598567 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $16.34 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153463026 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.